AzTrials
AzTrials

Nicotine DependenceNCT06163872

Doctors' Perspective on Tobacco Addiction

An observational study of Nicotine Dependence, run by Karadeniz Technical University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

ABSTRACT Aim: Our study aimed to determine the approaches of our physicians to the smoking habits of their patients other than those with pulmonary diseases. Method: Patients examined in different outpatient clinics of our hospital will be asked 7 questions about the doctor's approach to smoking habits. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Nicotine Dependence
What is being tested?
survey study
How many people
941 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 May 2023to 30 Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients who were examined in other branch outpatient clinics other than the chest diseases department of our hospital

Who may be able to join

  • Patients who were examined in other branch outpatient clinics other than the chest diseases department of our hospital

Who cannot join

  • Those who did not volunteer to participate in the survey
  • Patients under the age of 18
  • patients whose mental status was not suitable for the survey

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Department of Chest Diseases, Division Of Intensive Care Medicine, Faculty of Medicine, Karadeniz Technical University

    Trabzon, 61100

Other trials in Turkey (Türkiye)

About this study

Official title: Approaches of Doctors in Different Branches to the Smoking Habits of Their Patients; Patient's Perspective Survey Study

ABSTRACT

Aim:

Read more

Our study aimed to determine the approaches of our physicians to the smoking habits of their patients other than those with pulmonary diseases.

Method:

Patients examined in different outpatient clinics of our hospital will be asked 7 questions about the doctor's approach to smoking habits.

  1. Do you have information about smoking cessation clinic? 2) Has your doctor asked if you smoke? 3) Did he suggest you stop using it? 4) Did he inform you about the relationship between smoking and your disease? 5) Did he provide information about smoking cessation outpatient clinic services? 6) Have you ever thought about quitting smoking after your doctor's briefing? 7) Did you quit smoking after your doctor's briefing?
Read the detailed description
  1. INTRODUCTION: Tobacco use can cause many health problems with both its direct effects on all systems and passive smoke exposure (1). Tobacco use is very common in the world and ranks second among the most common causes of death. According to the World Health Organization, 20.2% of people aged 15 and over smoke and more than 8 million people die each year from active smoking. The mortality rates due to passive smoking are too high to be underestimated, and approximately 1.2 million people are lost due to health problems and second-hand smoke exposure (2). The prevalence of tobacco use among adults (aged 15 and over) is 31.2% (48% in men and 15% in women). Regular smoking is especially common between the ages of 25-44. Studies show that smoking rates in Turkey are inversely proportional to the level of education (3). Physicians are the most influential ones on tobacco use behavior. Informing patients about tobacco addiction, helping with treatment, and drawing a sample profile by not using tobacco is a profile that every physician should portray. Today, smoking cessation support is provided by specialist physicians (Chest diseases, Family medicine) to help smokers quit. In this process, patients are supported with both behavioral treatment and medical treatment (4-5). However, this support should not be limited to the specified sections. The physician evaluating a patient should contribute to tobacco control regardless of his/her branch, learn whether the patient is using tobacco or not, advise the patient to quit if he/she is using it, and should inform and direct the patient from smoking cessation outpatient clinics. In this study, it is aimed to evaluate the attitudes and habits of our physicians working in non-chest disease departments in our hospital and to determine their role in developing a positive attitude towards patients. With the results of the study, it is aimed to question the smoking habits of physicians in patients, to be a guide and leader, to reveal the differences in physician approaches according to branches, to be a guide for initiatives to increase positive attitudes by analyzing positive and negative results and self-criticism.
  2. MATERIALS-METHODS:

The study will start after the approval of the faculty ethics committee. Patients who were examined in other branch outpatient clinics other than the chest diseases department of our hospital will questioned for 3 months. Those who did not volunteer to participate in the survey, patients under the age of 18, and patients whose mental status was not suitable for the survey will not included in the study. As the place where the questionnaire will be conducted, the blood collection laboratory where all the patients come mostly was chosen, and the patients who came here to donate blood were randomly selected and the questionnaire was conducted. In addition to their demographic characteristics, the following 7 questions were asked to the patients. 1) Do you know about smoking cessation outpatient clinic? 2) Has your doctor asked if you smoke? 3) Has he suggested you stop using it? 4) Has he informed you about the relationship of smoking with your illness? 5) Has s/he informed about smoking cessation outpatient clinic services? 6) Have you ever considered quitting smoking after your doctor's briefings? 7) Have you quitted smoking after your doctor's briefings? The responses will compared according to the branches.

It will investigated whether the patients asked the questions specified in the data form about their demographic characteristics, educational status, diagnosis, the branch they were examined in, the recommendations of the examining physician regarding the patient's smoking habit and whether they quit if they smoked.

2.1.Statistical Analysis The suitability of the data for normal distribution will examined with the ShapiroWilk and Kolmogorog Smirnov tests. Kruskall-Wallis, Mann-Whitney U, student-t and chi-square tests will used for intergroup comparisons. General linner modeling, Wilcowon and Friedman tests will used in serial follow-up data. Data will presented as percentage, mean (std deviation) and median (minimum-maximum). Pearson's chi-square test will used to compare the qualitative data. Categorical data will presented as frequency and percentage.

Being tested
survey study
Keywords
Tobacco, smoking, doctor, patients, health care
Medical subject headings
Tobacco Use Disorder, Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • survey studyBehavioural

    survey study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nicotine addiction

    Determining how effective doctors working in branches other than pulmonology are in helping smokers quit smoking.

    Measured: 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2023
  2. Study start1 May 2023
  3. Primary completion30 Jul 2023
  4. Study completion30 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
941 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06163872
Sponsor's protocol ID
Protocol No: 2022/143
Status last verified
Dec 2023
First submitted
3 Oct 2023
Last updated
11 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Nicotine Dependence, run by Karadeniz Technical University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nicotine addiction (time frame: 3 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in